Cite

HARVARD Citation

    Gökbuget, N. et al. (2020). Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia. Leukemia & lymphoma. 61 (11), pp. 2665-2673. [Online]. 
  
Back to record